Anlon Healthcare schedules Q4FY26 earnings call on June 3
Anlon Healthcare Limited has announced an earnings conference call scheduled for June 03, 2026, at 04:00 PM IST to review the audited financial results for the quarter and fiscal year ended March 31, 2026. The session will be led by Mr. Punit Rasadia, Chairman & Managing Director, and will focus on publicly available information without disclosing any unpublished price-sensitive information. The company has engaged ConfideLeap Partners to manage the event, requiring participants to register via a provided Zoom link.

*this image is generated using AI for illustrative purposes only.
Anlon Healthcare Limited has scheduled an earnings conference call for June 03, 2026, to discuss the audited financial results for the quarter and year ended March 31, 2026. The meeting is set to begin at 04:00 PM IST and will be led by Mr. Punit Rasadia, Chairman & Managing Director.
The company stated that the discussion will be based on publicly available information and documents. No unpublished price-sensitive information (UPSI) is proposed to be discussed during the interactions with investors and analysts.
The notification was submitted to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The invite was signed by Punitkumar Rasadia, Managing Director.
Conference Call Details
| Detail | Information |
|---|---|
| Date | Wednesday, June 03, 2026 |
| Time | 04:00 PM IST |
| Speaker | Mr. Punit Rasadia – Chairman & Managing Director |
| Registration Link | https://zoom.us/webinar/register/WN_LWh-jf2_TM6GXzKI9QQI-A |
| Webinar ID | 950 8884 3165 |
| Passcode | 318258 |
Participants are required to register prior to joining the webinar. The company has engaged ConfideLeap Partners to facilitate the investor call.
Historical Stock Returns for Anlon Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.81% | +4.06% | -3.35% | -91.74% | -84.90% | -84.90% |
What strategic initiatives is Anlon Healthcare pursuing to drive growth in the upcoming fiscal year?
How might the company's financial performance impact its stock valuation and investor sentiment post-earnings call?
What are the potential risks or challenges Anlon Healthcare could face in the current market environment?

























